Log in to save to my catalogue

Restoring the Angiogenic Capacity of the Human Diabetic Adipose-derived mesenchymal stem cells Prime...

Restoring the Angiogenic Capacity of the Human Diabetic Adipose-derived mesenchymal stem cells Prime...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_238f8aaf55ec423c8d4661d79bae876c

Restoring the Angiogenic Capacity of the Human Diabetic Adipose-derived mesenchymal stem cells Primed with Deferoxamine as a Hypoxia Mimetic Agent: Role of HIF-1α

About this item

Full title

Restoring the Angiogenic Capacity of the Human Diabetic Adipose-derived mesenchymal stem cells Primed with Deferoxamine as a Hypoxia Mimetic Agent: Role of HIF-1α

Publisher

Tabriz University of Medical Sciences

Journal title

Advanced pharmaceutical bulletin, 2023-03, Vol.13 (2), p.350-360

Language

English

Formats

Publication information

Publisher

Tabriz University of Medical Sciences

More information

Scope and Contents

Contents

Purpose: Insufficient angiogenesis is associated with serious diabetic complications. Recently, adipose-derived mesenchymal stem cells (ADScs) are known to be a promising tool causing therapeutic neovascularization. However, the overall therapeutic efficacy of these cells is impaired by diabetes. This study aims to investigate whether in vitro phar...

Alternative Titles

Full title

Restoring the Angiogenic Capacity of the Human Diabetic Adipose-derived mesenchymal stem cells Primed with Deferoxamine as a Hypoxia Mimetic Agent: Role of HIF-1α

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_238f8aaf55ec423c8d4661d79bae876c

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_238f8aaf55ec423c8d4661d79bae876c

Other Identifiers

ISSN

2228-5881

E-ISSN

2251-7308

DOI

10.34172/apb.2023.021

How to access this item